Bio-Rad Laboratories, Inc. Class A Common Stock (BIO)

Stockholders Equity

$7.17B

Quarterly · Period ending: · USD

BIO logo

BIO Stockholders Equity

Latest reported$7.17B
BIO Quarterly Shareholders Equity ($29.90M → $7.17B)
High-resolution chart · PNG

BIO stockholders equity history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Bio-Rad Laboratories, Inc. Class A Common Stock Stockholders Equity — Quarterly (USD)
Period endingStockholders Equity (USD)
7,173,900,000
6,851,300,000
7,453,600,000
6,736,800,000
7,128,700,000
6,679,400,000
6,569,300,000
7,487,859,000
6,778,787,000
9,051,134,000
8,741,133,000
8,416,198,000
8,446,893,000
9,763,716,000
9,615,252,000
8,453,605,000
8,922,597,000
10,182,916,000
13,685,236,000
15,332,378,000
11,594,880,000
10,609,059,000
9,879,940,000
8,825,145,000
7,353,402,000
6,293,079,000
5,755,057,000
5,131,192,000
5,486,810,000
4,863,855,000
4,020,331,000
4,900,481,000
4,638,946,000
4,488,091,000
2,930,250,000
2,848,447,000
2,810,997,000
2,707,466,000
2,579,160,000
2,702,691,000
2,614,561,000
2,544,449,000
2,490,503,000
2,429,729,000
2,358,897,000
2,198,513,000
2,185,155,000
2,176,730,000
2,249,944,000
2,232,603,000
2,186,722,000
2,124,240,000
2,070,942,000
2,031,217,000
2,015,005,000
1,934,882,000
1,851,888,000
1,839,649,000
1,743,937,000
1,693,149,000
1,725,834,000
1,612,292,000
1,536,696,000
1,423,832,000
1,285,131,000
1,282,187,000
1,259,726,000
1,208,661,000
1,110,181,000
1,026,612,000
1,041,139,000
1,050,235,000
1,114,558,000
1,082,267,000
971,690,000
946,340,000
896,799,000
860,664,000
819,538,000
784,740,000
756,114,000
702,655,000
657,974,000
648,957,000
628,644,000
624,286,000
596,888,000
553,839,000
544,520,000
518,322,000
495,807,000
459,339,000
448,594,000
414,005,000
383,087,000
356,525,000
340,914,000
304,935,000
283,877,000
272,321,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.